Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention

Prolonged enoxaparin therapy compared with standard-of-care antithrombotic therapy in opiate-treated patients undergoing primary percutaneous coronary intervention

A novel enoxaparin regimen consisting of intra-arterial bolus (0.75 mg/kg) followed by intravenous infusion (0.75 mg/kg/6 hours) has been developed as a possible solution to the delayed absorption of oral P2Y12 inhibitors in opiate-treated ST-elevation myocardial infarction (STEMI) patients undergoi...

Full description

Bibliographic Details
Main Authors: Wael Sumaya, William A.E. Parker, Heather M. Judge, Ian R. Hall, Rachel C. Orme, Zulfiquar Adam, James D. Richardson, Alexander M.K. Rothman, Kenneth P. Morgan, Julian P. Gunn, Robert F. Storey
Format: Article
Language:English
Published: Taylor & Francis Group 2021-05-01
Series:Platelets
Subjects:
enoxaparin
glycoprotein iib/iiia inhibitors
p2y12 inhibitor
primary percutaneous coronary intervention
st-elevation myocardial infarction
unfractionated heparin
Online Access:http://dx.doi.org/10.1080/09537104.2020.1779925

Internet

http://dx.doi.org/10.1080/09537104.2020.1779925

Similar Items